Patents by Inventor Mohammad A. Elkalay

Mohammad A. Elkalay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Removal of selected factors from whole blood or its components
    Patent number: 5730713
    Abstract: This invention provides a composition, device and method for the removal of selected factors, such as cytokines or pharmaceuticals, from a substance such as whole blood or plasma. Advantageously, the invention provides for the treatment or prevention of septic shock syndrome or other conditions evidenced by the presence of cytokines in a patient by contacting the patient's whole blood with a composition comprising silica and a surface treatment material, such as heparin, but preferably human serum albumin (HSA). The treatment lowers the cytokine concentration of the blood. Pharmaceuticals can be removed from an individual's whole blood or plasma, such as for use in treating drug overdosage.
    Type: Grant
    Filed: June 3, 1996
    Date of Patent: March 24, 1998
    Assignee: Rhone-Poulenc Rorer Pharmaceuticals Inc.
    Inventors: Thomas B. Okarma, John Blankenship, Abraham T. Lin, Mohammad A. Elkalay
  • Removal of selected factors from whole blood or its components
    Patent number: 5523096
    Abstract: This invention provides a composition, device and method for the removal of selected factors, such as cytokines or pharmaceuticals, from a substance such as whole blood or plasma. Advantageously, the invention provides for the treatment or prevention of septic shock syndrome or other conditions evidenced by the presence of cytokines in a patient by contacting the patient's whole blood with a composition comprising silica and a surface treatment material, such as heparin, but preferably human serum albumin (HSA). The treatment lowers the cytokine concentration of the blood. Pharmaceuticals can be removed from an individual's whole blood or plasma, such as for use in treating drug overdosage.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: June 4, 1996
    Assignee: Applied Immune Sciences, Inc.
    Inventors: Thomas B. Okarma, John Blankenship, Abraham T. Lin, Mohammad A. Elkalay
  • Removal of selected factors from whole blood or its components; and prevention and treatment of septic shock syndrome
    Patent number: 5437861
    Abstract: This invention provides a composition, device and method for the treatment or prevention of septic shock syndrome or other conditions evidenced by the presence of cytokines in a patient by contacting the patient's whole blood with a composition comprising silica and a surface treatment material, such as heparin, but preferably human serum albumin (HSA). The treatment lowers the cytokine concentration of the blood.
    Type: Grant
    Filed: March 16, 1993
    Date of Patent: August 1, 1995
    Assignee: Applied Immune Sciences, Inc.
    Inventors: Thomas B. Okarma, John Blankenship, Abraham T. Lin, Mohammad A. Elkalay